Aquisição de Bevacizumab - 2024 - ULSLO, EPE.

ID 11010557 · Portal BASE
Price
Base Price
€1,421 .00
Effective Price
€1,421 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
1
Winner
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Company
Competition
1 bidder recorded
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Dates
Publication
06 Nov 2024
Celebration
25 Oct 2024
Contracting Entity
Centro Hospitalar de Lisboa Ocidental, EPE
NIF 507618319
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 60 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
06 Nov 2024
Signing Date
25 Oct 2024
Days Late
12
Rule
A2/A3 late publication: 12 days after signing (threshold: 10)
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17